Securities and Exchange Commission

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent

Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.

Compare To Other Companies

Annual (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
-0.0377	2018-03-15	10-K	2017	FY	2016-01-01	2016-12-31	CY2016
-0.0172	2019-03-07	10-K	2018	FY	2017-01-01	2017-12-31	CY2017
-0.0637	2020-03-16	10-K	2019	FY	2018-01-01	2018-12-31	CY2018
-0.0339	2021-03-11	10-K	2020	FY	2019-01-01	2019-12-31	CY2019
-0.288	2022-03-17	10-K	2021	FY	2020-01-01	2020-12-31	CY2020
-0.009	2023-03-29	10-K	2022	FY	2021-01-01	2021-12-31	CY2021
-0.024	2024-03-13	10-K	2023	FY	2022-01-01	2022-12-31	CY2022
-0.054	2024-03-13	10-K	2023	FY	2023-01-01	2023-12-31	CY2023

All Reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
-0.0377	2018-03-15	10-K	2017	FY	2016-01-01	2016-12-31	CY2016
-0.0172	2018-03-15	10-K	2017	FY	2017-01-01	2017-12-31
-0.0172	2019-03-07	10-K	2018	FY	2017-01-01	2017-12-31	CY2017
-0.0637	2019-03-07	10-K	2018	FY	2018-01-01	2018-12-31
-0.0637	2020-03-16	10-K	2019	FY	2018-01-01	2018-12-31	CY2018
-0.0339	2020-03-16	10-K	2019	FY	2019-01-01	2019-12-31
-0.0339	2021-03-11	10-K	2020	FY	2019-01-01	2019-12-31	CY2019
-0.159	2021-03-11	10-K	2020	FY	2020-01-01	2020-12-31
-0.288	2022-03-17	10-K	2021	FY	2020-01-01	2020-12-31	CY2020
-0.009	2022-03-17	10-K	2021	FY	2021-01-01	2021-12-31
-0.009	2023-03-29	10-K	2022	FY	2021-01-01	2021-12-31	CY2021
-0.024	2023-03-29	10-K	2022	FY	2022-01-01	2022-12-31
-0.024	2024-03-13	10-K	2023	FY	2022-01-01	2022-12-31	CY2022
-0.054	2024-03-13	10-K	2023	FY	2023-01-01	2023-12-31	CY2023